These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4406481)

  • 21. Hormonal and metabolic effects of moderate exercise in type I-diabetics with hypo- and hyperinsulinemia.
    Zander E; Schulz B; Woltansky P; Wulfert P; Chlup R
    Acta Univ Palacki Olomuc Fac Med; 1985; 111():281-6. PubMed ID: 2949507
    [No Abstract]   [Full Text] [Related]  

  • 22. Morning peripheral insulin effectiveness and night changes in growth hormone, blood glucose and basal insulin needs in patients with type 1 diabetes mellitus.
    Borissova AM; Kozlovski P; Popova J; Kirilov G
    Diabete Metab; 1992; 18(6):463-4. PubMed ID: 1297604
    [No Abstract]   [Full Text] [Related]  

  • 23. [The criterion of metabolic control in type I diabetics].
    Heinze E
    Monatsschr Kinderheilkd; 1985 Jun; 133(6):363-6. PubMed ID: 3900699
    [No Abstract]   [Full Text] [Related]  

  • 24. D-Trp8-D-Cys14-somatostatin--demonstration of its differential suppressive activity in juvenile diabetics.
    Neuhaus C; Kerner W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):115-8. PubMed ID: 395066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human growth hormone secretion after double stimulation with arginine in normal and insulin-dependent diabetic women.
    Koncz L; Soeldner S; Balodimos MC; Boden G; Gleason RE; Younger D
    Diabetes; 1973 Sep; 22(9):694-705. PubMed ID: 4728208
    [No Abstract]   [Full Text] [Related]  

  • 26. The Mauriac syndrome.
    Najjar S; Ayash MA
    Clin Pediatr (Phila); 1974 Sep; 13(9):723-5. PubMed ID: 4416595
    [No Abstract]   [Full Text] [Related]  

  • 27. 24-Hour urinary glucose excretion in assessment of control in juvenile diabetes mellitus.
    Levinsky RJ; Trompeter RS; Grant DB
    Arch Dis Child; 1976 Jun; 51(6):463-6. PubMed ID: 942241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone in insulin-treated diabetes mellitus.
    Sabeh G; Mendelsohn LV; Corredor DG; Sunder JH; Friedman LM; Morgan CR; Danowski TS
    Metabolism; 1969 Sep; 18(9):748-53. PubMed ID: 5343866
    [No Abstract]   [Full Text] [Related]  

  • 29. Physical training in juvenile diabetes.
    Koivisto VA; Groop L
    Ann Clin Res; 1982; 14 Suppl 34():74-9. PubMed ID: 6756276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of three days of blood glucose normalization by means of an "artificial endocrine pancreas" on the concentrations of growth hormone, glucagon, and cortisol in juvenile diabetics.
    Schock A; Schultz M; Kerner W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):93-6. PubMed ID: 395097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of insulin therapy on the profiles of plasma immunoreactive glucagon in juvenile-type and adult-type diabetics.
    Raskin P; Unger RH
    Diabetes; 1978 Apr; 27(4):411-9. PubMed ID: 640246
    [No Abstract]   [Full Text] [Related]  

  • 32. Pediatric management problems. Early morning hyperglycemia with ketonuria.
    Quinn L; Clemmings L
    Pediatr Nurs; 1993; 19(3):246-8. PubMed ID: 8511005
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolic and growth patterns in transient neonatal diabetes.
    Schiff D; Colle E; Stern L
    N Engl J Med; 1972 Jul; 287(3):119-22. PubMed ID: 5032272
    [No Abstract]   [Full Text] [Related]  

  • 34. 24-hour studies of the effects of somatostatin on the levels of plasma growth hormone, glucagon, and glucose in normal subjects and juvenile diabetics.
    Christensen SE; Hansen AP; Weeke J; Lundbaek K
    Diabetes; 1978 Mar; 27(3):300-6. PubMed ID: 640235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of diabetics with the use of a microprocessor: comparison of insulin treatments based on blood and urine glucose levels.
    Hermányi I; Tamás G
    Acta Diabetol Lat; 1988; 25(1):33-40. PubMed ID: 3043988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative clinical evaluation of a new proprietary method for urine testing in juvenile diabetics.
    Traisman HS; Greenwood RD
    Clin Pediatr (Phila); 1973 Jun; 12(6):357-9. PubMed ID: 4709563
    [No Abstract]   [Full Text] [Related]  

  • 37. Growth hormone levels in diabetes. Correlation with the clinical control of the disease.
    Vigneri R; Squatrito S; Pezzino V; Filetti S; Branca S; Polosa P
    Diabetes; 1976 Mar; 25(3):167-72. PubMed ID: 1254109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
    Giugliano D; Luyckx AS; Lefebvre PJ
    Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Insulin therapy and behaviors of insulin antagonist hormones, with special reference to the reactions of growth hormone and cortisol during the hypoglycemic stage in juvenile diabetes].
    Egi S
    Horumon To Rinsho; 1978 Sep; 26(9):947-51. PubMed ID: 719944
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of sleep-induced growth hormone secretion: no effect on diabetic control.
    Davidson MB; Peters AL
    Diabetes Care; 1990 Jul; 13(7):813-4. PubMed ID: 2257001
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.